Maxim analyst Allen Klee raised the firm’s price target on CareCloud to $12 from $11 and keeps a Buy rating on the shares. The company’s investor day presentation highlights its transformation to a full service provider with multiple growth opportunities, the analyst tells investors in a research note. Klee adds that he expects CareCloud’s new digital health solutions to be the key driver to accelerate organic growth to the high single-digit range from low single-digits starting in 2024.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on MTBC:
- CareCloud Hosts Inaugural Analyst and Investor Day, Emphasizes Goal to Help Providers Embrace the Next Generation of Healthcare
- CareCloud to host virtual analyst and investor day
- CareCloud to participate in a webinar with Ladenburg Thalmann
- CareCloud’s medSR Division Chosen by Russell Medical Center to Implement New Electronic Health Record Platform
- CareCloud’s medSR division chosen by Russell Medical Center